| Introduction

　　Song Shijun, professor, chief physician, member of the Communist Party of China, has been engaged in clinical tumor work for more than 40 years, and he has acquired CACA Guideline For Holistic Integrative Management Of Cancer Expert Certificate, once served as the deputy director of the Department of Internal Medicine of the Third Affiliated Hospital of Xinxiang Medical College.

　　He is good at chemotherapy, minimally invasive treatment, biological therapy and targeted therapy of various solid tumors, especially in the treatment of thoracic tumors such as esophageal cancer, lung cancer, breast cancer and lymphoma, digestive tract tumors such as gastric cancer and colorectal cancer, and other tumors;

　　 He has extensive experience in the diagnosis and treatment of liver cancer, ovarian cancer, cervical cancer, bladder cancer, prostate cancer and other tumors, as well as clinically difficult malignant tumors;

　　 He has extensive experience in minimally invasive treatment technologies such as interventional therapy, argon-helium scalpel, radiofrequency ablation, microwave ablation, and radioactive iodine seed implantation therapy;

　　In the long-term clinical work on tumors, Director Song actively researched and accumulated rich results. He has successively participated in 2 projects of the National Natural Science Foundation of China, 3 projects of the local department level, presided over 1 project of the scientific and technological research project of Xinxiang City, and published 20 papers. He has published more than 10 papers, including 3 SCI papers, and participated in the preparation of 6 academic monographs.

| Education Background：

　　Clinical Medicine, Zhejiang Medical University

　　Studying in the master class of clinical oncology in Shanxi Medical University

　　 Advanced Training In Beijing China-Japan Friendship Hospital

　　Advanced Training In Cancer Hospital of Chinese Academy of Medical Sciences

　　Advanced Training In Nanfang Hospital of Southern Medical University

| Medical Experience： 

　　 Member of China Anti-Cancer Association and Chinese Society of Clinical Oncology (CSCO)

　　Member of American Society of Oncology (ASCO)

　　Member of the European Society of Oncology (ESMO)

　　Member of Henan Anti-Cancer Association

　　Member of the Standing Committee of Tumor and Chemotherapy Professional Committee of Henan Anti-Cancer Association

　　Member of Standing Committee of Cancer Precision Medicine Therapy Professional Committee of Henan Anti-Cancer Association

　　Member of Standing Committee of Tumor Molecular Medicine Therapy Professional Committee of Henan Anti-Cancer Association

　　Member of the Professional Committee of Tumor Biotherapy of Henan Anti-Cancer Association

　　Member of the Lung Cancer Professional Committee of Henan Anti-Cancer Association

　　Member of Esophageal Cancer Professional Committee of Henan Anti-Cancer Association

　　Member of the Professional Committee of Liver Cancer and Biliary Tract Tumor of Henan Anti-Cancer Associati

　　Member of Breast Cancer Professional Committee of Henan Anti-Cancer Association

　　Member of Cancer Drug Clinical Branch of Henan Anti-Cancer Association

　　Member of Neuroendocrine Tumor Professional Committee of Henan Anti-Cancer Association

　　Expert Committee of Medical Malpractice and Medical Damage Appraisal of Henan Medical Association

| Research Direction：

　Tumor

| Expert papers：

　　Effect of Radiofrequency Ablation Therapy on Immune Function for Lung Cancer Patients

　　Authors: Song Shijun, Liu Shuai

　　Source: Journal of Clinical Psychosomatic Diseases, Vol. 22, No. 3, May 2016

　 【Abstract】Objective: To investigate the effect of radiofrequency ablation therapy on immune function in lung cancer patients. Conclusion: Radiofrequency ablation therapy significantly enhances immune function in lung cancer patients and plays an important role in comprehensive lung cancer treatment.

　　Effect of Radiofrequency Ablation Therapy on Immune Function for Liver Cancer Patients

　　Authors: Song Shijun, Bai Liyun, Shen Jiahui, Zhao Hongdan, Guo Kang, Li Junpeng, Wang Xia

　　Source: Journal of Clinical Psychosomatic Diseases, Vol. 25, No. 3, May 2019

　 【Abstract】Objective: To investigate the Effect of radiofrequency ablation therapy on immune function in liver cancer patients. Conclusion: Patients with primary liver cancer have immunosuppression, and radiofrequency ablation can significantly improve patients’immune function.

　　Clinical Application Value of Palliative Therapy for Advanced Gastrointestinal Malignant Tumors

　　Authors: Li Shaoyi, Qi Aixia, Song Shijun, Bai Liyun

　　Source: China Practical Medicine, Vol. 11, No. 9, March 2016

　 【Abstract】Objective: To evaluate the clinical application value of palliative therapy for advanced gastrointestinal malignant tumors. Conclusion: Brucea javanica oil emulsion injection combined with Compound Kushen (Sophora flavescens Aiton) Injection (CKI) demonstrates significant clinical efficacy in treating advanced gastrointestinal malignancies, improving patients' quality of life and alleviating disease-related suffering.

　　Clinical Analysis of Continuous Hyperthermic Peritoneal Perfusion Chemotherapy for Advanced Gastric Cancer Patients with Malignant Seroperitoneum

　   Authors: Song Shijun, Zhao Hongdan, Li Shaoyi, Bai Liyun, Guo Kang

　   Source: China Health Standard Management, Vol. 5, No. 6

　 【Abstract】Objective: To analyze the clinical efficacy of Continuous Hyperthermic Peritoneal Perfusion Chemotherapy in advanced gastric cancer patients with ascites and evaluate the feasibility of this treatment. Conclusion: Continuous Hyperthermic Peritoneal Perfusion Chemotherapy yields more significant clinical efficacy than chemotherapy alone in treating advanced gastric cancer with ascites, improves patients' quality of life, and holds substantial clinical application value.

　　Expression and Clinical Significance of BCSG1 Protein in Breast Cancer Tissues

　　Authors: Song Shijun, Wang Quanzhi

　　Source: Medical & Pharmaceutical Journal of Chinese People's Liberation Army, Vol. 28, No. 3, March 2016

　 【Abstract】Objective: To investigate the expression of breast cancer-specific gene 1 (BCSG1) and of its protein in breast cancer tissues, and analyze their relationship with clinicopathological features as well as their clinical significance in treatment and prognosis. Conclusion: BCSG1 mRNA and protein are abnormally overexpressed in breast cancer tissues, correlating with clinical staging, lymph node metastasis, and prognosis. This overexpression may serve as a risk factor for breast cancer progression.

　　Clinical Study of FPLC Multiple Submucosal Injection on Lymph Node Metastasis for Rectal Cancer

　　Authors: Song Shijun, Wang Quanzhi

　　Source: Journal of Colorectal & Anal Surgery, Vol. 22, No. 1, 2016

　 【Abstract】Objective: To investigate the effect of compound fluorouracil polyphase liposome (FPLC) Multiple submucosal injection on lymph node metastasis for rectal cancer. Conclusion: FPLC Multiple injection effectively inhibits postoperative lymph node metastasis and micrometastasis in rectal cancer patients, promotes apoptosis of cancer cells, suppresses proliferation, and ultimately reduces local recurrence rates. 

　　Clinical Observation of L-OHP Combined with Capecitabine Treatment for Advanced Colorectal Cancerr

　　Authors: Song Shijun, Shen Jiahui

　　Source: Chinese Journal of Modern Drug Application, Vol. 2, No. 1, January 2008

　 【Abstract】Objective: To observe the efficacy and adverse reactions of oxaliplatin (L-OHP) combined with capecitabine in treating advanced colorectal cancer. Conclusion: The oxaliplatin-capecitabine regimen demonstrates high efficacy, manageable toxicity, good patient tolerance, and improved quality of life.

　　Clinical Observation of PTX Combined with LFP Regimen for Advanced Esophageal Cancer

　　Authors: Song Shijun, Shen Jiahui

　　Source: China Practical Medicine, Vol. 3, No. 18, June 2008

　 【Abstract】Objective: To observe the short-term efficacy and adverse reactions of paclitaxel (PTX) combined with the LFP(PLFP) regimen in treating advanced esophageal cancer. Conclusion: The PLFP regimen shows favorable efficacy and tolerable toxicity in treating advanced esophageal cancer, making it a viable therapeutic option.

　　Clinical Study on the Synergistic and Detoxifying Effects of High-Dose Astragalus in Advanced Cancer Chemotherapy

　　Authors: Liu Shixia, Zhang Guolin, Tan Zhihua, Song Shijun

　　Source: Clinical Focus, Vol. 18, No. 16, August 20, 2003

　 【Abstract】Objective: To observe the synergistic and detoxifying effects of high-dose Astragalus in chemotherapy for advanced cancer. Conclusion: High-dose Astragalus injection combined with chemotherapy inhibits tumor progression and reduces toxicity while enhancing therapeutic efficacy.

　　Clinical Observation of Endostar Combined with Capecitabine treatment for Advanced Breast Cancer

　　Authors: Song Shijun, Jia Liang

　　Source: China Practical Medicine, Vol. 3, No. 12, April 2008

　 【Abstract】Objective: To evaluate the efficacy and safety of recombinant human endostatin (Endostar) combined with capecitabine in treating advanced breast cancer. Conclusion: Endostar combined with capecitabine exhibits synergistic effects, high efficacy, minimal side effects, and improved quality of life, warranting further clinical investigation.

　　Application Value of Thromboelastography in Blood Transfusion for Liver Cancer Patients

　　Authors: Shen Jiahui, Song Shijun

　　Source: Journal of Clinical Psychosomatic Diseases, Vol. 22, No. 5, September 2016

　 【Abstract】Objective: To explore the value of thromboelastography (TEG) in comprehensively assessing coagulation function and guiding blood component transfusion for liver cancer patients. Conclusion: TEG reduces unnecessary blood transfusions, prevents blood waste, lowers transfusion risks, and alleviates patients' financial burden, outperforming traditional detection methods.